The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma
- PMID: 34967592
- PMCID: PMC9080362
- DOI: 10.31557/APJCP.2021.22.12.4075
The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma
Abstract
Objective: MicroRNAs (miRNAs) are key post-transcriptional regulators of protein translation in humans. They have an essential role in various cancers, including nasopharyngeal carcinoma (NPC). The abnormal expression of miR-21 has been proven to be associated with various types of cancers, including NPC, through its targets. This study provides a systematic view of the roles of miR-21 and its network of targets (hsa-miR-21-3p, hsa-miR-21-5p) that are associated with nasopharyngeal carcinoma.
Methods: Bioinformatics tools were applied to predict the targets of miR-21. Interactions among the targets of hsa-miR-21-3p/5p were found by the gene MANIA online tool.
Results and conclusion: It was found that the target genes are involved in vital biological processes in cancer. In detail, a total of 95 targets of miR-21 were recorded to be associated with NPC. Therefore, they may provide new insights into nasopharyngeal pathogenesis and bring about novel targets for NPC diagnosis as well as therapy in near future.
Keywords: Nasopharyngeal carcinoma; miR-21; miRNA; target gene.
Figures


Similar articles
-
Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.Med Sci Monit. 2016 Jun 28;22:2215-34. doi: 10.12659/msm.896047. Med Sci Monit. 2016. PMID: 27350400 Free PMC article.
-
An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.BMC Med Genomics. 2012 Jan 19;5:3. doi: 10.1186/1755-8794-5-3. BMC Med Genomics. 2012. PMID: 22260379 Free PMC article.
-
miRNA profiling of human nasopharyngeal carcinoma cell lines HONE1 and CNE2 after X-ray therapy.Adv Clin Exp Med. 2022 Jun;31(6):671-687. doi: 10.17219/acem/146580. Adv Clin Exp Med. 2022. PMID: 35275451
-
Emerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities.Int J Biol Sci. 2022 Mar 28;18(7):2714-2728. doi: 10.7150/ijbs.70292. eCollection 2022. Int J Biol Sci. 2022. PMID: 35541920 Free PMC article. Review.
-
Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma.Genes (Basel). 2022 Jun 27;13(7):1160. doi: 10.3390/genes13071160. Genes (Basel). 2022. PMID: 35885944 Free PMC article. Review.
Cited by
-
Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sjögren's Syndrome: A public databases-based study.PLoS One. 2024 Feb 15;19(2):e0298447. doi: 10.1371/journal.pone.0298447. eCollection 2024. PLoS One. 2024. PMID: 38359008 Free PMC article.
-
Cuproptosis related ceRNA axis AC008083.2/miR-142-3p promotes the malignant progression of nasopharyngeal carcinoma through STRN3.PeerJ. 2024 Aug 12;12:e17859. doi: 10.7717/peerj.17859. eCollection 2024. PeerJ. 2024. PMID: 39148682 Free PMC article.
-
Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma.Int J Med Sci. 2022 Aug 21;19(9):1482-1501. doi: 10.7150/ijms.73404. eCollection 2022. Int J Med Sci. 2022. PMID: 36035369 Free PMC article.
-
Comment on "The Diagnostic and Prognostic Value of miR‑155 in Cancers: An Updated Meta‑analysis".Mol Diagn Ther. 2024 Jul;28(4):507-508. doi: 10.1007/s40291-024-00710-4. Epub 2024 May 23. Mol Diagn Ther. 2024. PMID: 38780684 No abstract available.
-
Equine mesenchymal stem cell derived extracellular vesicle immunopathology biomarker discovery.J Extracell Biol. 2023 May 28;2(6):e89. doi: 10.1002/jex2.89. eCollection 2023 Jun. J Extracell Biol. 2023. PMID: 38938916 Free PMC article.